Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study. 4. November 2022 A Jakob, M-O Zahn, A Nusch, T Werner, R Schnell, M Frank, N Hamm, K-U Däßler, C Losem, M Welslau, P Hoevel, K Potthoff, 2022. Journal of Bone Oncology, Volume 33, 2022. https://doi.org/10.1016/j.jbo.2022.100420 FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma – A novel validated prognostic score to facilitate treatment decision-making in real-world. Marschner N, Hegewisch-Becker S, Reiser M, von der Heyde E, Bertram M, Hollerbach SH, Kreher S, Wolf T, Binninger A, Chiabudini M, Kaiser-Osterhues A, Jänicke… Weiterlesen Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients. Hillebrand L, E, Söling U, Marschner N, 2022. Oncol Res Treat 2022;45:423-429. doi: 10.1159/000521826… Weiterlesen